Risk Adapted Treatment of Unilateral Favorable Histology Wilms Tumors (FHWT)
This phase III trial studies using risk factors in determining treatment for children with favorable tissue (histology) Wilms tumors (FHWT). Wilms Tumor is the most common type of kidney cancer in children, and FHWT is the most common subtype. Previous large clinical trials have established treatment plans that are likely to cure most children with FHWT, however some children still have their cancer come back (called relapse) and not all survive. Previous research has identified features of FHWT that are associated with higher or lower risks of relapse. The term "risk" refers to the chance of the cancer coming back after treatment. Using results of tumor histology tests, biology tests, and response to therapy may be able to improve treatment for children with FHWT.
开始日期2024-12-31
申办/合作机构-
100 项与 Reactive oxygen species x Top II x DNA 相关的临床结果
登录后查看更多信息
100 项与 Reactive oxygen species x Top II x DNA 相关的转化医学
登录后查看更多信息
0 项与 Reactive oxygen species x Top II x DNA 相关的专利(医药)